UK disability statistics: Prevalence and life experiences
An estimated 16.1 million people in the UK had a disability in 2022/23, accounting for 24% of the total population.
A debate will be held in the Commons Chamber on Thursday 5 November 2020 on the UK Government’s role in ensuring innovation and equitable access to treatment within the international covid-19 response. The debate will be opened by Wendy Chamberlain MP and Sarah Champion MP. The subject for the debate has been nominated by the Backbench Business Committee.
The following sources may provide useful background to the topic of this debate.
WHO press release, 24 April 2020
WHO press release, 14 August 2020
Department for International Development and Foreign Office press release, 24 April 2020
WHO press release, 21 September 2020
Boost for global response to COVID-19 as economies worldwide formally sign up to COVAX facility
Prime Minister’s Office press release, 26 March 2020
G20 Leaders’ Summit – statement on COVID-19: 26 March 2020
European Commission press release, 24 April 2020
Questions and Answers: The Coronavirus Global Response
The Guardian, 29 September 2020
Larry Elliott
World Bank announces $12bn plan for poor countries to buy Covid vaccines
Journal of Medical Ethics blog, August 4, 2020
Aisling McMahon
Patents, private governance and access to vaccines and treatments for Covid-19
The Conversation, 16 July 2020
BMJ Opinion blog, 3 June 2020
BMJ Opinion blog, May 19 2020
Santino Severoni, Director Migration and Health, World Health Organization and Jozef Bartovic, Technical Officer, WHO Regional Office for Europe
Equitable access to covid-19 vaccine for all must include refugees and migrants
LSE blog by Kashvi Shetty, April 29th, 2020
COVID-19 Vaccine: A Global Call for Equitable Access to Medicines
The Economist, April 24 2020
The Lancet Volume 396, Issue 10254, P800-802, September 19, 2020
Alexandra L Phelan, Mark Eccleston-Turner, Michelle Rourke, Allan Maleche, Chenguang Wang
Legal agreements: barriers and enablers to global equitable COVID-19 vaccine access
Nature, 6 October 2020
John N. Nkengasong, Nicaise Ndembi, Akhona Tshangela, Tajudeen Raji
COVID-19 vaccines: how to ensure Africa has access
The Lancet Global Health Volume 8, Issue 6, June 01, 2020
Luca Li Bassi, Lenias Hwenda
COVID-19: time to plan for prompt universal access to diagnostics and treatments
Nuffield Council on Bioethics Rapid Policy Briefing, 29 May 2020
Fair and equitable access to COVID-19 treatments and vaccines
Wellcome report summary, 22 May 2020
What people think about global access to COVID-19 treatments and vaccines
PQ96746, Developing Countries: Drugs, answered 5 October 2020
PQ77764, Coronavirus: Vaccination, answered 7 September 2020
PQ70465, USA: Remdesivir, answered 13 July 2020
PQ70464, USA: Coronavirus, answered 13 July 2020
PQ64864, Coronavirus: Vaccination, answered 2 July 2020
PQ54998, Developing Countries: Coronavirus, answered 10 June 2020
Parliamentary Office of Science & Technology (POST) Rapid Response, 6 July 2020
House of Lords Library, In Focus, 8 October 2020
Covid-19 Vaccine: Access for low and middle income countries
An estimated 16.1 million people in the UK had a disability in 2022/23, accounting for 24% of the total population.
There will be a debate on Lord Darzi's Independent Investigation into NHS Performance on Monday 7 October 2024. This debate will take place in the House of Commons chamber.
The Infected Blood Public Inquiry recommended that the government should set up a compensation scheme for those infected and affected by contaminated blood, blood products and tissue. The government accepted this recommendation and made regulations to establish the Infected Blood Compensation Scheme in August 2024.